Cancer and interstitial lung disease.

Area of Science:

• Pulmonary Medicine
• Oncology
• Rheumatology

Background:

• Interstitial lung diseases (ILDs) are a group of heterogeneous disorders.
• The relationship between ILDs and the development of cancer is an area of ongoing research.
• Understanding these links is crucial for patient management and risk stratification.

Purpose of the Study:

• To review and assess the contribution of various ILDs to cancer development.
• To summarize current evidence on the association between specific ILDs and increased cancer risk.
• To identify knowledge gaps in the pathogenesis of ILD-associated cancers.

Main Methods:

• Systematic literature review of studies investigating ILD and cancer.
• Analysis of epidemiological data and case reports.
• Synthesis of evidence regarding specific ILD types and their association with lung cancer and other malignancies.

Main Results:

• Idiopathic pulmonary fibrosis, systemic sclerosis, and pneumoconioses are associated with an increased risk of lung cancer.
• Evidence is insufficient to link sarcoidosis, rheumatoid arthritis, or systemic lupus erythematosus to solid tumors or hematologic malignancies.
• Sjögren's syndrome shows an increased incidence of lymphoma, while dermatomyositis and polymyositis have a documented association with various cancers.

Conclusions:

• The precise mechanisms linking ILDs to cancer require further elucidation.
• Additional research is necessary to clarify the causal relationships and underlying pathways.
• Improved understanding will aid in developing targeted prevention and treatment strategies for patients with ILDs.